The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis

Serum S100A8/A9 and S100A12 Levels in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinical Inactive Disease During and Flare after Discontinuation of Anti-TNF Therapy

(2018) Claas H. Hinze et al.   Arthritis & Rheumatology

MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis

(2015) Janneke Anink et al.   ARTHRITIS RESEARCH & THERAPY

Biomarkers in systemic juvenile idiopathic arthritis

(2014) Nanguneri Nirmala et al.   CURRENT OPINION IN RHEUMATOLOGY

MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis

(2013) Ivy Y Choi et al.   ANNALS OF THE RHEUMATIC DISEASES

The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis

(2012) Dirk Holzinger et al.   ANNALS OF THE RHEUMATIC DISEASES

Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever

(2009) T. Kallinich et al.   ANNALS OF THE RHEUMATIC DISEASES

The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1β form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis

(2009) Michael Frosch et al.   ARTHRITIS AND RHEUMATISM

S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin

(2008) Helmut Wittkowski et al.   ARTHRITIS AND RHEUMATISM